| Report ID | 278293 |
| Drug Identification Number | 02505223 |
| Brand name | BIJUVA |
| Common or Proper name | estradiol and progesterone capsules |
| Company Name | KNIGHT THERAPEUTICS INC. |
| Market Status | MARKETED |
| Active Ingredient(s) | ESTRADIOL PROGESTERONE |
| Strength(s) | 1MG 100MG |
| Dosage form(s) | CAPSULE |
| Route of administration | ORAL |
| Packaging size | 30-count |
| ATC code | G03FA |
| ATC description | |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | 2026-02-18 |
| Actual start date | 2026-02-18 |
| Estimated end date | Unknown |
| Actual end date | |
| Shortage status | Actual shortage |
| Updated date | 2026-02-23 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 100 ALEXIS-NIHON BLVD., SUITE 600 MONTREAL, QUEBEC CANADA H4M 2P2 |
| Company contact information |
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v3 | 2026-02-23 | English | Compare |
| v2 | 2026-02-18 | French | Compare |
| v1 | 2026-02-18 | English | Compare |
Showing 1 to 3 of 3